ºÐÀÚÇ¥ÀûÄ¡·á(MTT) ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀ忹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ Ç¥Àû¿ä¹ý ½ÃÀå : À¯Çü, ÀÛ¿ë±âÀü, À¯Åë ä³Î, Ä¡·á ¿µ¿ªº° ¿¹Ãø(2025-2030³â)
Targeted Therapy Market by Type (Monoclonal Antibodies, Small Molecule Medicines), Mechanism of Action (Angiogenesis Inhibitors, Apoptosis Inducers, Gene Expression Modulators), Distribution Channel, Therapeutic Area - Global Forecast 2025-2030
¹ßÇà 2024³â 10¿ù
°¡°Ý
US $ 3,939
£Ü 5,597,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Ç×ü¾à¹°Á¢ÇÕü(ADC) ½ÃÀå
Antibody Drug Conjugates (ADC)
¹ßÇà 2024³â 10¿ù
°¡°Ý
US $ 5,600
£Ü 7,958,000 (ºÎ°¡¼¼ º°µµ)
|
¾ÆÀϸ®¾Æ ½ÃÀå : Ä¡·á Ŭ·¡½º, Åõ¿© ¹æ¹ý, ȯÀÚ À¯Çü, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Eylea Market by Therapeutic Class (Age-Related Macular Degeneration, Diabetic Macular Edema, Retinal Disorders), Mode Of Administration (Intravitreal Injection, Ocular Implants), Patient Type, End-User - Global Forecast 2025-2030
¹ßÇà 2024³â 10¿ù
°¡°Ý
US $ 3,939
£Ü 5,597,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÀÌÁß Ç¥Àû ¿ä¹ý ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Dual Targeted Therapy Market by Type (Combination Therapy, Single Drug Therapy), Application (Autoimmune Diseases, Cardiovascular Diseases, Infectious Diseases), End User, Drug Administration Route, Therapy Mechanism - Global Forecast 2025-2030
¹ßÇà 2024³â 10¿ù
°¡°Ý
US $ 3,939
£Ü 5,597,000 (ºÎ°¡¼¼ º°µµ)
|
´ÜŬ·ÐÇ×ü ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Monoclonal Antibodies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
¹ßÇà 2024³â 10¿ù
°¡°Ý
US $ 4,900
£Ü 6,963,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¾Ï Ç×ü¾à¹°Á¢ÇÕü ½ÃÀå : ±Ô¸ð, ¾àÁ¦ ½ÂÀÎ, ¾à°¡, ÆǸÅ, ÀÓ»ó½ÃÇè ÀλçÀÌÆ®(2030³â)
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030
¹ßÇà 2024³â 10¿ù
°¡°Ý
US $ 4,200
£Ü 5,968,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ PROTAC(´Ü¹éÁú ºÐÇØ Ç¥Àû Å°¸Þ¶ó) ½ÃÀå : ½ÃÀå ±âȸ¿Í ÀÓ»ó½ÃÇè µ¿Çâ(2027³â)
Global PROTAC Targeted Protein Degraders Market Opportunity & Clinical Trials Insight 2027
¹ßÇà 2024³â 10¿ù
°¡°Ý
US $ 4,200
£Ü 5,968,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ´ÜŬ·ÐÇ×ü ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, °ø±Þ¿ø À¯Çüº°, »ý»ê À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® - »ê¾÷ ¿¹Ãø(2024-2031³â)
Monoclonal Antibodies Market Size, Share, Growth Analysis, By Source Type, By Production Type, By Application, By End-use, By Region - Industry Forecast 2024-2031
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,300
£Ü 7,531,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¾ÐŸ¸Ó ½ÃÀå - ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : À¯Çüº°, ¿ëµµº°, Áö¿ªº° »ê¾÷ ¿¹Ãø(2024-2031³â)
Aptamers Market Size, Share, Growth Analysis, By Type(Nucleic Acid and Peptide), By Application(Diagnostics, Therapeutics, Research & Development, Others), By Region - Industry Forecast 2024-2031
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,300
£Ü 7,531,000 (ºÎ°¡¼¼ º°µµ)
|
Ç×ü¾à¹°Á¢ÇÕü(ADC) : ±â¼ú ¹× ¼¼°è ½ÃÀå
Antibody-Drug Conjugates: Technologies and Global Markets
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 4,650
£Ü 6,608,000 (ºÎ°¡¼¼ º°µµ)
|
Ç×ü ÀǾàÇ° : ±â¼ú ¹× ¼¼°è ½ÃÀå
Antibody Drugs: Technologies and Global Markets
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 4,650
£Ü 6,608,000 (ºÎ°¡¼¼ º°µµ)
|
Ç×ü¾à¹°°áÇÕü ½ÃÀå º¸°í¼ : ÄÄÆ÷³ÍÆ®, Ÿ±ê, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)
Antibody Drug Conjugates Market Report by Component, Target, Application, End User, and Region 2024-2032
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 3,899
£Ü 5,540,000 (ºÎ°¡¼¼ º°µµ)
|
Ç×ü ¶óÀ̺귯¸® ±â¼ú ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2033³â)
Antibody Library Technology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 4,900
£Ü 6,963,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ºÐÇØ Ç×ü º¹ÇÕü(DAC) ½ÃÀå : ¾÷°èÀÇ °üÁ¡¿¡¼ º» ÀÌÇØ°ü°èÀÚ¡¤±â¼ú¡¤ÆÄÀÌÇÁ¶óÀΡ¤Á¦ÈÞÀÇ »óȲ ºÐ¼®(2024³â)
Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 2,050
£Ü 2,913,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÀÌÁß Æ¯À̼º Ç×ü ¾à¹° º¹ÇÕü ½ÃÀå : ÀÓ»ó½ÃÇè, ¾à»ç ½ÂÀÎ, ÇâÈÄ ½ÃÀå ±âȸ Àü¸Á(2029³â)
Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 4,200
£Ü 5,968,000 (ºÎ°¡¼¼ º°µµ)
|
CD137 Ç×ü ÀÓ»ó½ÃÇè ¹× ½ÃÀå ±âȸ¿¡ ´ëÇÑ ÀλçÀÌÆ®(2027³â)
CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 3,000
£Ü 4,263,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¿¬±¸¿ë Ç×ü ½ÃÀå(2024³â)
2024 Market Report for Research Antibodies
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 8,000
£Ü 11,368,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Ç×ü ¶óÀ̺귯¸® ±â¼ú ½ÃÀå
Antibody Library Technologies
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,950
£Ü 7,034,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Æı¹Àû Ç×ÀÎÁöÁú Ç×ü ÁõÈıº ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ - Ä¡·áº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Catastrophic Antiphospholipid Syndrome Market Size, Share & Trends Analysis Report By Treatment (Anticoagulants, Immunosuppressive Therapy, Plasma Exchange Therapy), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,950
£Ü 8,455,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÀÌÁß Æ¯À̼º Ç×ü ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Bispecific Antibodies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,900
£Ü 6,963,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Å°Æ®·ç´Ù(Keytruda) ½ÃÀå º¸°í¼(2024³â)
Keytruda Global Market Report 2024
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,000
£Ü 7,105,000 (ºÎ°¡¼¼ º°µµ)
|
¾ÐŸ¸Ó ½ÃÀå º¸°í¼ : À¯Çüº°, ¿ëµµº°, Áö¿ªº°(2024-2032³â)
Aptamers Market Report by Type (Nucleic Acid, Peptide), Application (Diagnostics, Therapeutics, Research and Developments, and Others), and Region 2024-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 3,899
£Ü 5,540,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Æ÷À¯·ù Æú¸®Å¬·Î³Î IgG Ç×ü ½ÃÀå º¸°í¼ : À¯Çü, Á¦Ç°, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°(2024-2032³â)
Mammalian Polyclonal IgG Antibody Market Report by Type, Product, Application, End Use, and Region 2024-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 3,899
£Ü 5,540,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå º¸°í¼ : Á¦Ç° À¯Çü, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº°(2024-2032³â)
Molecular Cytogenetics Market Report by Product Type, Technology (Comparative Genomic Hybridization, Fluorescence in SITU Hybridization, Immunohistochemistry, Karyotyping, and Others), Application, End User, and Region 2024-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 3,899
£Ü 5,540,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¶ó´ÏºñÁÖ¸¿(Ranibizumab) ½ÃÀå º¸°í¼(2024³â)
Ranibizumab Global Market Report 2024
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,000
£Ü 7,105,000 (ºÎ°¡¼¼ º°µµ)
|